TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT05755828 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05521204 — Predictive Biomarker (PRD): FGFR1 mRNA
Genes: FGFR1; BFGFR; CEK; FGFBR; FLG; FLT2; HBGFR
Study NCT05362760 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05362760 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05618093 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT05618093 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05242094 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05137795 — Predictive Biomarker (PRD): VIP mRNA
Genes: VIP
Study NCT05851560 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT01144156 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01144156 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03620318 — Predictive Biomarker (PRD): PDGFRA mRNA
Genes: PDGFRA; PDGFR2; RHEPDGFRA
Study NCT06227728 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05139134 — Safety Biomarker (SAF): C-X-C motif chemokine 5
Genes: CXCL5; ENA78; SCYB5
Study NCT05650047 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT06662812 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT06304987 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT06231498 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study NCT06477991 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT06663787 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05051124 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05404698 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05694533 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT05755217 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05901324 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05700253 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06089486 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAV1 mRNA
Genes: CAV1; CAV
Study NCT05025722 — Predictive Biomarker (PRD): PDXP mRNA
Genes: PDXP; CIN; PLP; PLPP
Study NCT05694936 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05241054 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04750122 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04750122 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT04964050 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT06419816 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04700566 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05809869 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT06234813 — Predictive Biomarker (PRD): TFPI mRNA
Genes: TFPI; LACI; TFPI1
Study NCT05363605 — Predictive Biomarker (PRD): FGFR3 mRNA
Genes: FGFR3; JTK4
Study NCT05002530 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT05002530 — Predictive Biomarker (PRD): STRA6 mRNA
Genes: STRA6; PP14296; UNQ3126/PRO10282/PRO19578
Study NCT05002530 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT06646445 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT05995041 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study NCT05995041 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT04855760 — Predictive Biomarker (PRD): REL mRNA
Genes: REL
Study NCT05459636 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06448442 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT05077098 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT04921358 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05107362 — Predictive Biomarker (PRD): GAST mRNA
Genes: GAST; GAS
Study NCT05986903 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05986903 — Safety Biomarker (SAF): HLA-DQA1
Genes: CELIAC1
Study NCT06566274 — Predictive Biomarker (PRD): TTN mRNA
Genes: TTN
Study NCT05421078 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04199819 — Monitoring Biomarker (MOI): HBV DNA
Study NCT05188898 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06412952 — Predictive Biomarker (PRD): GRPR mRNA
Genes: GRPR
Study NCT04679909 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05549154 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT05657132 — Surrogate Endpoint (SUR): Bacterial count
Study NCT04722757 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT06102798 — Predictive Biomarker (PRD): LSS mRNA
Genes: LSS; OSC
Study NCT05087953 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT04826926 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT05230251 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05418686 — Safety Biomarker (SAF): Interleukin 1
Study NCT06103487 — Predictive Biomarker (PRD): IDUA mRNA
Genes: IDUA
Study NCT05027685 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05964751 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT05964751 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05598606 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05172518 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04590209 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06121817 — Predictive Biomarker (PRD): TEF mRNA
Genes: TEF; KIAA1655
Study NCT06121817 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05932264 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT05707481 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04759365 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT04915313 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04922645 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study NCT06025357 — Predictive Biomarker (PRD): CIT mRNA
Genes: CIT; CRIK; KIAA0949; STK21
Study NCT06478108 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT06478108 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06478108 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT06478108 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT06051552 — Predictive Biomarker (PRD): MMD mRNA
Genes: MMD; PAQR11
Study NCT05927233 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05458856 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT05491603 — Predictive Biomarker (PRD): DBI mRNA
Genes: DBI
Study NCT05252325 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05563467 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT04835233 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05887622 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05561868 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT05338541 — Pharmacodynamic Biomarker (PDY): Histone acetylation
Study NCT04676477 — Predictive Biomarker (PRD): ERBB3 mRNA
Genes: ERBB3; HER3
Study NCT04676477 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00002254 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04689152 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT06427694 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT05208775 — Predictive Biomarker (PRD): ESD mRNA
Genes: ESD
Study NCT06354192 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06341127 — Predictive Biomarker (PRD): KCNC1 mRNA
Genes: KCNC1
Study NCT05580731 — Predictive Biomarker (PRD): IVNS1ABP mRNA
Genes: IVNS1ABP; ARA3; FLARA3; KIAA0850; KLHL39; NS1; NS1BP; HSPC068
Study NCT05080842 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05080842 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT05080842 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06573164 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT06436586 — Safety Biomarker (SAF): Human leucocyte antigen
Study NCT05610059 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04768868 — Predictive Biomarker (PRD): WEE1 mRNA
Genes: WEE1
Study NCT04795700 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT06664736 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT06664736 — Safety Biomarker (SAF): BDNF
Study NCT06664736 — Safety Biomarker (SAF): Interleukin 1
Study NCT06664736 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06664736 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06663943 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT06263530 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05679791 — Predictive Biomarker (PRD): HGS mRNA
Genes: HGS; HRS
Study NCT05606991 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT05606991 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06285539 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study NCT05239676 — Predictive Biomarker (PRD): CXADR mRNA
Genes: CXADR; CAR
Study NCT05856318 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05554042 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT04473768 — Predictive Biomarker (PRD): NTS mRNA
Genes: NTS
Study NCT06038994 — Predictive Biomarker (PRD): TRAF3IP2 mRNA
Genes: TRAF3IP2; C6orf2; C6orf4; C6orf5; C6orf6
Study NCT05558813 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT04152213 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06578832 — Surrogate Endpoint (SUR): Serum calcium
Study NCT05119140 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05119140 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT04964778 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05802693 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05818514 — Predictive Biomarker (PRD): CCR9 mRNA
Genes: CCR9; GPR28
Study NCT05619640 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05619640 — Predictive Biomarker (PRD): KL mRNA
Genes: KL
Study NCT05619640 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT05619640 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT04357496 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06172712 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study NCT05682482 — Predictive Biomarker (PRD): DIO2 mRNA
Genes: DIO2; ITDI2; TXDI2
Study NCT05809895 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT06572592 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study NCT04655404 — Pharmacodynamic Biomarker (PDY): Tropomyosin-related kinase A
Genes: NTRK1; MTC; TRK; TRKA
Study NCT05721040 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04515329 — Predictive Biomarker (PRD): SLURP1 mRNA
Genes: SLURP1; ARS
Study NCT05164146 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04803929 — Predictive Biomarker (PRD): LILRB4 mRNA
Genes: LILRB4; ILT3; LIR5
Study NCT05683600 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06546488 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT04996082 — Predictive Biomarker (PRD): SRC mRNA
Genes: SRC; SRC1
Study NCT04721002 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study NCT04711304 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06449781 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT04635085 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT05388890 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study NCT05668793 — Predictive Biomarker (PRD): KCNA3 mRNA
Genes: KCNA3; HGK5
Study NCT05668793 — Predictive Biomarker (PRD): OTOP2 mRNA
Genes: OTOP2
Study NCT05668793 — Predictive Biomarker (PRD): GNB4 mRNA
Genes: GNB4
Study NCT05443477 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06103513 — Predictive Biomarker (PRD): IGF1 mRNA
Genes: IGF1; IBP1
Study NCT05068440 — Predictive Biomarker (PRD): CD79B mRNA
Genes: CD79B; B29; IGB
Study NCT05068440 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT05463224 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06418399 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT06336382 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT05558436 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT05558436 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05213325 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05213325 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT06295549 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05597527 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT05909722 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study NCT04795414 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05480449 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05370599 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05238363 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05352971 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study NCT05911802 — Predictive Biomarker (PRD): MYD88 mRNA
Genes: MYD88
Study NCT05911802 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT05911802 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT04520074 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT05756049 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT05690737 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05691426 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study NCT05735080 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05735080 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): CCNE1 mRNA
Genes: CCNE1; CCNE
Study NCT05735080 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05735080 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05735080 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT06144333 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04863638 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04660721 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT04970693 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05017441 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05370547 — Predictive Biomarker (PRD): PMAIP1 mRNA
Genes: PMAIP1; NOXA
Study NCT05225181 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT06385652 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT06406829 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05012943 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05676697 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT05518526 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study NCT05271929 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04920851 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05872204 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT06300203 — Safety Biomarker (SAF): IL4
Genes: BSF1; IL-4; BCGF1; BCGF-1; MGC79402
Study NCT06300203 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT05501821 — Predictive Biomarker (PRD): CD9 mRNA
Genes: CD9; MIC3; TSPAN29; GIG2
Study NCT06386952 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05040763 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06165068 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT06377579 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study NCT06377579 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT06377579 — Pharmacodynamic Biomarker (PDY): 2-hydroxyglutarate
Study NCT04986280 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05418556 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study NCT06198855 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06065709 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05706597 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study NCT04930003 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04266457 — Pharmacodynamic Biomarker (PDY): Synuclein alpha
Genes: SNCA; NACP; PARK1
Study NCT04934085 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05608785 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05559619 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06386705 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT06386705 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT06386705 — Pharmacodynamic Biomarker (PDY): Tropomyosin-related kinase A
Genes: NTRK1; MTC; TRK; TRKA
Study NCT06386705 — Predictive Biomarker (PRD): CDK8 mRNA
Genes: CDK8
Study NCT04726059 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05533268 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06265220 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT04607876 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06483386 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05446701 — Predictive Biomarker (PRD): AQP4 mRNA
Genes: AQP4
Study NCT06134583 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAV1 mRNA
Genes: CAV1; CAV
Study NCT04838964 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06172998 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06060197 — Predictive Biomarker (PRD): SLC16A2 mRNA
Genes: SLC16A2; MCT7; MCT8; XPCT
Study NCT06569069 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT06211647 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT00029757 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06547060 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05334277 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05334277 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00015483 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06243497 — Predictive Biomarker (PRD): UCP1 mRNA
Genes: UCP1; SLC25A7; UCP
Study NCT05298800 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04852419 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study NCT05958199 — Predictive Biomarker (PRD): HHLA2 mRNA
Genes: HHLA2
Study NCT05958199 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05958199 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06224556 — Predictive Biomarker (PRD): CGA mRNA
Genes: CGA
Study NCT00464282 — Predictive Biomarker (PRD): SLC7A5 mRNA
Genes: SLC7A5; CD98LC; LAT1; MPE16
Study NCT00464282 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study NCT06426797 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT06222489 — Predictive Biomarker (PRD): ERBB3 mRNA
Genes: ERBB3; HER3
Study NCT04150692 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT05276895 — Predictive Biomarker (PRD): NLRP3 mRNA
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study NCT06076811 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05390502 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04487457 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT04487457 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04487457 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT04487457 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05933434 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT04749849 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05730517 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05732883 — Surrogate Endpoint (SUR): Serum calcium
Study NCT05489874 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06364124 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT06364124 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05068271 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT05068271 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT05068271 — Safety Biomarker (SAF): BDNF
Study NCT05170789 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT05170789 — Predictive Biomarker (PRD): SLAMF7 mRNA
Genes: SLAMF7; CS1; UNQ576/PRO1138